Yes, pharmaceutical companies face significant reputation risks, especially when it comes to the development and marketing of cancer treatments. Issues such as drug recalls, side effects, or unethical practices in clinical trials can lead to public outcry and loss of trust. This can result in decreased stock prices and stringent regulatory scrutiny.
